Chairman of Vitame Group and Vita Middle East Pharma, Dr. Tamer Mohamed El-Saady, has affirmed that Egypt holds all the necessary capabilities to become a regional and global powerhouse for pharmaceuticals and dietary supplements. He revealed that the group is aggressively pushing forward with a massive expansion strategy, backed by initial-phase investments exceeding EGP 400 million.

According to El-Saady, the strategy features an advanced facility in Sadat City dedicated to dietary supplements, built to the highest international benchmarks. Parallel to this, the group is establishing a pharmaceutical plant equipped with cutting-edge production lines, a move designed to sharpen the company’s competitive edge both at home and abroad.

El-Saady emphasized that the group’s vision revolves around localizing pharmaceutical manufacturing and enticing global players to produce in Egypt for export to regional and international markets. He noted that the company has already succeeded in bringing several multinational firms from Spain, France, and Italy on board to manufacture their products within Egyptian facilities.

“Egypt boasts a robust infrastructure, a highly strategic location, and key trade agreements that position it perfectly as a global industrial hub—especially with the government’s mounting support for the manufacturing and export sectors,” El-Saady added.

Highlighting their current footprint, El-Saady disclosed that Vitame Group already has over 55 pharmaceutical and nutritional products active across Gulf markets, with dozens more currently clearing regulatory approvals. Looking ahead, he stressed that the next phase will focus on driving further international expansion while transferring world-class technology into the Egyptian market.